Ganesh Shanmugam, MS, MCh, FRCS, FRCSC, Lauren L. Clark, BSc, Hayley J

Slides:



Advertisements
Similar presentations
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Advertisements

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Manuel J. Antunes, MD, PhD, DSc 
Surgery for congenital diseases of the aorta
Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification 
The impact of frailty on outcomes after cardiac surgery: A systematic review  Aresh Sepehri, BSc, Thomas Beggs, Ansar Hassan, MD, PhD, FRCSC, Claudio Rigatto,
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Stephen D. Cassivi, MD, MSc, FRCSC, FACS 
Kathy J. Jenkins, MD, MPH, Kimberlee Gauvreau, ScD, Jane W
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
The surgical and interventional hybrid era: Experiences from China
Ground glass opacity of the lung: The veil that needs lifting
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Precise capture of thoracic morbidity and mortality: Essential to the process and culture of quality improvement  Anna L. McGuire, MD, MSc, FRCSC, John.
Assessing surgical risk for adults with congenital heart disease: Are pediatric scoring systems appropriate?  Brian Kogon, MD, Matthew Oster, MD, MPH 
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Should lung transplantation be performed using donation after cardiac death? The United States experience  David P. Mason, MD, Lucy Thuita, MS, Joan M.
Timing of surgery for pulmonary embolism: An evolving paradigm
Incidence and treatment of chylothorax after cardiac surgery in children: Analysis of a large multi-institution database  Carlos M. Mery, MD, MPH, Brady.
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease  Matthew E. Oster, MD, Matthew J.
Gabriel Loor, MD, Liang Li, PhD, Joseph F
Is tissue the issue?  Brian E. Louie, MD, MHA, MPH, FRCSC, FACS 
Conduit conundrum: If not two, why three?
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC 
Benjamin G. Arenson, BSc, Lindsey A. MacDonald, BSc, Hilary P
Cost, quality, and value in coronary artery bypass grafting
Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant  George J. Arnaoutakis, MD, Timothy J.
The search for the holy grail of lobectomy
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Military surgeons just want to have fun
Experience from an American Association for Thoracic Surgery Foundation for Thoracic Surgery Training Fellowship: Lung transplantation in Toronto General.
The Journal of Thoracic and Cardiovascular Surgery
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery  Vivek Sharma, MD, FRCA, Vivek Rao, MD,
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Replicating the success of mitral valve repair in the aortic valve
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Increased extracorporeal membrane oxygenation center case volume is associated with improved extracorporeal membrane oxygenation survival among pediatric.
Commentary: Do the right thing! Ethical versus legal
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Using bilateral internal thoracic arteries—just do it
Who is your plastic surgeon
James I. Fann, MD, John E. Connolly, MD 
Functional tricuspid pathology: To treat or not to treat
If airlines can do it, we can too…
Innovation in cardiothoracic surgical training
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?  Mara B. Antonoff,
Intraoperative adverse events can be compensated by technical performance in neonates and infants after cardiac surgery: A prospective study  Meena Nathan,
Constantine L. Athanasuleas, MD, FACC 
Early extubation after cardiac surgery: The evolution continues
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement 
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Outcomes of neonates requiring prolonged stay in the intensive care unit after surgical repair of congenital heart disease  Makoto Mori, MD, Courtney.
More than vital: Who bears the burden?
Direct comparison of risk-adjusted and non–risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes  Richard J. Novick, MD, Stephanie A.
Crane technique with the vacuum bell device for improving access in the Nuss procedure  Hany Elsayed, FRCS Cth  The Journal of Thoracic and Cardiovascular.
Presentation transcript:

Improving and standardizing capture of pediatric cardiac surgical complications  Ganesh Shanmugam, MS, MCh, FRCS, FRCSC, Lauren L. Clark, BSc, Hayley J. Burton, RNFA, Andrew E. Warren, MD, MSc, FRCPC, Stacy B. O’Blenes, MSc, MD, FRCS(C), Camille L. Hancock Friesen, MSc, MD, FRCS(C), FACS  The Journal of Thoracic and Cardiovascular Surgery  Volume 144, Issue 3, Pages 570-576 (September 2012) DOI: 10.1016/j.jtcvs.2012.01.070 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Cumulative sum (CUSUM) plot of mortality in the entire cohort. Using 3.5% as an “acceptable” mortality rate, according to our institutions’ historic rates and published data rates of current mortality in pediatric cardiac surgery cohorts, the slope of the curve remains between the alarm limits for the entire duration of the study, implying that program is “in control” with regard to mortality rates. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 570-576DOI: (10.1016/j.jtcvs.2012.01.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Total cohort complications stratified by the organ system. Complications were grouped according to the Multi-Societal Committee for Pediatric and Congenital Heart Disease classification. Most complications in our retrospective analysis were arrhythmias (14.5%) and cardiac (12.6%) and operative (12.6%) complications. The 16 complications (10.1%) classified as “other” included vascular or conduit thrombosis (n = 3), urinary tract or intravenous site infections (n = 3), gastrointestinal or genitourinary bleeding (n = 2), hypertension associated with recoarctation (n = 2), stridor (n = 2), aspiration (n = 1), hepatic dysfunction (n = 1), intussusception (n = 1), and a skin blister secondary to antiseptic skin preparation solution (n = 1). The Journal of Thoracic and Cardiovascular Surgery 2012 144, 570-576DOI: (10.1016/j.jtcvs.2012.01.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Complications stratified by surgical complexity. The highest complication frequency (white bars) and morbidity burden (black bars; calculated by summing the product of complications multiplied by the severity coefficient for a given surgical stratum) was in (A) Risk Adjustment for Congenital Heart Surgery (RACHS) category 3 and (B) Aristotle basic complexity (ABC) level 2. These were also the groups with the greatest number of procedures. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 570-576DOI: (10.1016/j.jtcvs.2012.01.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Risk-stratified complications indexed to the number of procedures in each surgical strata. There was a linear relationship between indexed morbidity (y axis; calculated as Σ[complication frequency × severity coefficient]/number of procedures per surgical strata) and complexity of the procedure (x axis) according to (A) Risk Adjustment for Congenital Heart Surgery (RACHS) category or (B) Aristotle basic complexity (ABC) level. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 570-576DOI: (10.1016/j.jtcvs.2012.01.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Cumulative sum (CUSUM) plot of complications in the total cohort. A, Plotting the occurrence of any complication versus procedure number generates a plot of overall program performance but does not incorporate the concept of frequency and severity into the graphic depiction of outcome. B, Three curves showing the dramatic effect on the slope of the line when one incorporates frequency and severity (morbidity burden in entire cohort) into the reporting of complications (upper curve) compared with simply plotting the occurrence of any complication (morbidity, lowest curve). It also illustrates the effect of including deaths in the analysis (upper curve) compared with excluding deaths from the analysis (morbidity burden in survivors, middle curve). The Journal of Thoracic and Cardiovascular Surgery 2012 144, 570-576DOI: (10.1016/j.jtcvs.2012.01.070) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions